Status:

COMPLETED

Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes

Lead Sponsor:

Gainesville Eye Associates

Collaborating Sponsors:

Science in Vision

Conditions:

Cataract

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

This study is designed to compare the effectiveness of LenSx laser arcuate relaxing incisions vs. manual (blade) arcuate relaxing incisions in patients with low, but significant, levels of astigmatism...

Detailed Description

This study is a comparative, prospective, randomized contralateral eye study of visual outcomes after LenSx laser arcuate relaxing incisions utilizing the Woodcock nomogram at 90% thickness vs. manual...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Subjects are eligible for the study if they meet the following criteria:
  • Note: Ocular criteria must be met in both eyes.
  • are willing and able to understand and sign an informed consent;
  • are willing and able to attend all study visits;
  • are more than 40 years of age, of either gender and any race;
  • are presenting for cataract surgery or refractive lens exchange with a desire to reduce astigmatism and will be implanted with a non-toric lens
  • have good ocular health, with no pathology that compromises visual acuity (outside of residual refractive error and cataract)
  • have 0.50 D to 1.75 D of regular corneal astigmatism
  • have potential acuity of 20/25 or better
  • Are scheduled to have a non-toric monofocal intraocular lens (IOL) (SN60WF) lens implanted in both eyes
  • Exclusion Criteria If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study.
  • Irregular astigmatism (e.g. keratoconus)
  • Corneal pathology (e.g. scar, dystrophy, pterygium, moderate-to-severe dry eye)
  • Monocular status (e.g. amblyopia)
  • Previous radial keratotomy, corneal refractive surgery or other corneal surgery (e.g. corneal transplant, lamellar keratoplasty)
  • Previous anterior or posterior chamber surgery (e.g., vitrectomy, laser iridotomy)
  • Diabetic retinopathy
  • Macular pathology (e.g. age-related macular degeneration, epiretinal membrane)
  • History of retinal detachment
  • Subjects who have an acute or chronic disease or illness that would confound the results of this investigation (e.g., immunocompromised, connective tissue disease, clinically significant atopic disease, diabetes, and any other such disease or illness), that are known to affect post-operative visual acuity.
  • Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.

Exclusion

    Key Trial Info

    Start Date :

    October 15 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 20 2021

    Estimated Enrollment :

    41 Patients enrolled

    Trial Details

    Trial ID

    NCT04126174

    Start Date

    October 15 2019

    End Date

    March 20 2021

    Last Update

    September 5 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Gainesville Eye Associates

    Gainesville, Georgia, United States, 30501